Literature DB >> 11755709

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

Serguei V Vinogradov1, Tatiana K Bronich, Alexander V Kabanov.   

Abstract

A new family of nanoscale materials on the basis of dispersed networks of cross-linked ionic and nonionic hydrophilic polymers is being developed. One example is the nanosized cationic network of cross-linked poly(ethylene oxide) (PEO) and polyethyleneimine (PEI), PEO-cl-PEI nanogel. Interaction of anionic amphiphilic molecules or oligonucleotides with PEO-cl-PEI results in formation of nanocomposite materials in which the hydrophobic regions from polyion-complexes are joined by the hydrophilic PEO chains. Formation of polyion-complexes leads to the collapse of the dispersed gel particles. However, the complexes form stable aqueous dispersions due to the stabilizing effect of the PEO chain. These systems allow for immobilization of negatively charged biologically active compounds such as retinoic acid, indomethacin and oligonucleotides (bound to polycation chains) or hydrophobic molecules (incorporated into nonpolar regions of polyion-surfactant complexes). The nanogel particles carrying biological active compounds have been modified with polypeptide ligands to enhance receptor-mediated delivery. Efficient cellular uptake and intracellular release of oligonucleotides immobilized in PEO-cl-PEI nanogel have been demonstrated. Antisense activity of an oligonucleotide in a cell model was elevated as a result of formulation of oligonucleotide with the nanogel. This delivery system has a potential of enhancing oral and brain bioavailability of oligonucleotides as demonstrated using polarized epithelial and brain microvessel endothelial cell monolayers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755709     DOI: 10.1016/s0169-409x(01)00245-9

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  109 in total

Review 1.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.

Authors:  Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

4.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

5.  Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.

Authors:  Carlos M Galmarini; Galya Warren; Madapathage T Senanayake; Serguei V Vinogradov
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

Review 6.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

7.  Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery.

Authors:  Jong Oh Kim; Hardeep S Oberoi; Swapnil Desale; Alexander V Kabanov; Tatiana K Bronich
Journal:  J Drug Target       Date:  2013-09-02       Impact factor: 5.121

Review 8.  Polymeric nanogel formulations of nucleoside analogs.

Authors:  Serguei V Vinogradov
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

9.  Colloidal microgels in drug delivery applications.

Authors:  Serguei V Vinogradov
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 10.  Nanostructured materials for applications in drug delivery and tissue engineering.

Authors:  Michael Goldberg; Robert Langer; Xinqiao Jia
Journal:  J Biomater Sci Polym Ed       Date:  2007       Impact factor: 3.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.